Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3740138)

Published in PeerJ on August 08, 2013

Authors

Alexander A Goldberg1, Vladimir I Titorenko, Adam Beach, J Thomas Sanderson

Author Affiliations

1: INRS-Institut Armand-Frappier , Laval, QC , Canada.

Articles citing this

Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat (2014) 0.92

The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes (Lond) (2015) 0.92

Empirical Validation of a Hypothesis of the Hormetic Selective Forces Driving the Evolution of Longevity Regulation Mechanisms. Front Genet (2016) 0.84

Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population. J Exerc Rehabil (2014) 0.82

Mechanisms underlying the anti-aging and anti-tumor effects of lithocholic bile acid. Int J Mol Sci (2014) 0.82

Optimization of low-frequency low-intensity ultrasound-mediated microvessel disruption on prostate cancer xenografts in nude mice using an orthogonal experimental design. Oncol Lett (2015) 0.77

Discovery of plant extracts that greatly delay yeast chronological aging and have different effects on longevity-defining cellular processes. Oncotarget (2016) 0.77

When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow? Curr Pharmacol Rep (2015) 0.77

A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis. Oncotarget (2016) 0.76

Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux. World J Gastroenterol (2014) 0.75

Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells. J Cancer Prev (2017) 0.75

Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells. PeerJ (2016) 0.75

Protein kinase C in the wood frog, Rana sylvatica: reassessing the tissue-specific regulation of PKC isozymes during freezing. PeerJ (2014) 0.75

Low-frequency ultrasound-mediated microvessel disruption combined with docetaxel to treat prostate carcinoma xenografts in nude mice: A novel type of chemoembolization. Oncol Lett (2016) 0.75

Biological Effects of Hesperetin on Interleukin-6/Phosphorylated Signal Transducer and Activator of Transcription 3 Pathway Signaling in Prostate Cancer PC3 Cells. Pharmacognosy Res (2017) 0.75

Articles cited by this

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91

Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev (2009) 5.11

A G protein-coupled receptor responsive to bile acids. J Biol Chem (2003) 4.76

Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov (2008) 4.43

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) (2011) 3.62

International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev (2005) 3.33

Bile acids as regulatory molecules. J Lipid Res (2009) 3.23

Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol (2007) 2.22

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85

N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem (2000) 1.80

Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis (2010) 1.79

Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer. Proc Natl Acad Sci U S A (2013) 1.76

Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes. Aging (Albany NY) (2010) 1.76

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69

Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med (1993) 1.57

Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol (2000) 1.51

Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biol (2011) 1.45

Cleavage of Bax enhances its cell death function. Exp Cell Res (2000) 1.36

A role of the bile salt receptor FXR in atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.30

TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. Drug Discov Today (2009) 1.22

Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. Oncologist (1997) 1.21

Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett (2003) 1.18

BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death Differ (2011) 1.18

Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood (2003) 1.16

Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes. Hepatology (2009) 1.12

TGR5: a novel target for weight maintenance and glucose metabolism. Exp Diabetes Res (2011) 1.12

Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun (2007) 1.12

Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. Trends Mol Med (2008) 1.03

TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. Mol Neurobiol (2012) 1.01

Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J Biol Chem (2008) 1.01

Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression. Oncogene (2011) 0.98

Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol Med (2004) 0.96

Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. Cell Mol Life Sci (2009) 0.96

Bile acids have the gall to function as hormones. Cell Metab (2009) 0.93

Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett (2003) 0.92

TGR5 as a therapeutic target for treating obesity. Curr Top Med Chem (2010) 0.91

Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. Oncol Rep (2012) 0.89

Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor. Int J Colorectal Dis (2004) 0.88

Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget (2011) 0.88

Metabolism: bile acids heat things up. Nature (2006) 0.87

The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal (2006) 0.87

The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. Eur J Cancer Prev (2012) 0.86

Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids. Curr Cancer Drug Targets (2006) 0.86

A quantitative assessment of the yeast lipidome using electrospray ionization mass spectrometry. J Vis Exp (2009) 0.86

Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proc Natl Acad Sci U S A (2012) 0.83

Articles by these authors

Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes. Aging (Albany NY) (2010) 1.76

Effect of calorie restriction on the metabolic history of chronologically aging yeast. Exp Gerontol (2009) 1.27

A new definition for the consensus sequence of the peroxisome targeting signal type 2. J Mol Biol (2004) 1.19

Mitochondrial membrane lipidome defines yeast longevity. Aging (Albany NY) (2013) 1.14

A signal from inside the peroxisome initiates its division by promoting the remodeling of the peroxisomal membrane. J Cell Biol (2007) 1.13

Lithocholic bile acid accumulated in yeast mitochondria orchestrates a development of an anti-aging cellular pattern by causing age-related changes in cellular proteome. Cell Cycle (2015) 1.10

Purification of mitochondria from yeast cells. J Vis Exp (2009) 1.08

Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci (2004) 1.01

Caloric restriction extends yeast chronological lifespan by altering a pattern of age-related changes in trehalose concentration. Front Physiol (2012) 0.98

Peroxisome division in the yeast Yarrowia lipolytica is regulated by a signal from inside the peroxisome. J Cell Biol (2003) 0.98

Integration of peroxisomes into an endomembrane system that governs cellular aging. Front Physiol (2012) 0.93

Dynamic ergosterol- and ceramide-rich domains in the peroxisomal membrane serve as an organizing platform for peroxisome fusion. J Cell Biol (2005) 0.93

A novel function of lipid droplets in regulating longevity. Biochem Soc Trans (2009) 0.92

Lithocholic acid extends longevity of chronologically aging yeast only if added at certain critical periods of their lifespan. Cell Cycle (2012) 0.91

Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells. Toxicol Sci (2005) 0.90

In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: a novel mechanism of action? Toxicol Appl Pharmacol (2006) 0.90

Macromitophagy is a longevity assurance process that in chronologically aging yeast limited in calorie supply sustains functional mitochondria and maintains cellular lipid homeostasis. Aging (Albany NY) (2013) 0.90

RNA interference of peroxisome-related genes in C. elegans: a new model for human peroxisomal disorders. Physiol Genomics (2002) 0.90

Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia. Biochim Biophys Acta (2012) 0.89

Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. J Agric Food Chem (2010) 0.89

A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase. Toxicol Lett (2004) 0.89

Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol Appl Pharmacol (2003) 0.88

Xenohormetic, hormetic and cytostatic selective forces driving longevity at the ecosystemic level. Aging (Albany NY) (2010) 0.88

Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget (2011) 0.88

Overproduction of translation elongation factor 1-alpha (eEF1A) suppresses the peroxisome biogenesis defect in a Hansenula polymorpha pex3 mutant via translational read-through. FEMS Yeast Res (2007) 0.86

A quantitative assessment of the yeast lipidome using electrospray ionization mass spectrometry. J Vis Exp (2009) 0.86

Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations. Chem Biol Interact (2010) 0.86

Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol Sci (2005) 0.85

Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. Toxicol Appl Pharmacol (2005) 0.85

A network of interorganellar communications underlies cellular aging. IUBMB Life (2013) 0.85

Essential roles of peroxisomally produced and metabolized biomolecules in regulating yeast longevity. Subcell Biochem (2013) 0.84

In search of housekeeping pathways that regulate longevity. Cell Cycle (2011) 0.84

Quasi-programmed aging of budding yeast: a trade-off between programmed processes of cell proliferation, differentiation, stress response, survival and death defines yeast lifespan. Cell Cycle (2014) 0.83

Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells. Prostate (2011) 0.83

Cells with impaired mitochondrial H2O2 sensing generate less •OH radicals and live longer. Antioxid Redox Signal (2014) 0.82

Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. Toxicol Sci (2004) 0.81

Mechanism of liponecrosis, a distinct mode of programmed cell death. Cell Cycle (2014) 0.80

Interspecies Chemical Signals Released into the Environment May Create Xenohormetic, Hormetic and Cytostatic Selective Forces that Drive the Ecosystemic Evolution of Longevity Regulation Mechanisms. Dose Response (2011) 0.79

No effect of CYP1B1 Val432Leu polymorphism on CYP1B1 messenger RNA levels in an organochlorine-exposed population in Slovakia. Cancer Epidemiol Biomarkers Prev (2005) 0.78

Suppression of aromatase activity in populations of bream (Abramis brama) from the river Elbe, Germany. Chemosphere (2006) 0.78

Lipids and lipid domains in the peroxisomal membrane of the yeast Yarrowia lipolytica. Biochim Biophys Acta (2006) 0.77

Evaluation of a bioluminescent mouse model expressing aromatase PII-promoter-controlled luciferase as a tool for the study of endocrine disrupting chemicals. Toxicol Appl Pharmacol (2010) 0.77

Metabolomic and lipidomic analyses of chronologically aging yeast. Methods Mol Biol (2014) 0.76

A unique co-culture model for fundamental and applied studies of human fetoplacental steroidogenesis and interference by environmental chemicals. Environ Health Perspect (2014) 0.76

Induction of ethoxy-resorufin-O-deethylase activity by halogenated aromatic hydrocarbons and polycyclic aromatic hydrocarbons in primary hepatocytes of the green frog (Rana esculenta). Environ Toxicol Chem (2005) 0.76

Inhibition of aromatase activity by methyl sulfonyl PCB metabolites in primary culture of human mammary fibroblasts. Toxicol Appl Pharmacol (2005) 0.75

Erratum: 3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and-independent prostate cancer cells. Genes Cancer (2016) 0.75

Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells. Toxicol Appl Pharmacol (2005) 0.75